Meningeal carcinomatosis from breast cancer treated with intrathecal trastuzumab

Lancet Oncology

Volumn 7, Issue 9, 2006, Pages 778-780

  Platini, Christian ^a   Long, Jérome ^a   Walter, Sabine ^a  

^a Bon Secours Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CA 15-3 ANTIGEN; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; LETROZOLE; METHOTREXATE; PACLITAXEL; PREDNISONE; PROGESTERONE RECEPTOR; TAMOXIFEN; THIOTEPA; TRASTUZUMAB;

ADULT; ARTICLE; BRAIN INFECTION; BREAST CANCER; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOENCEPHALOPATHY; LUMBAR PUNCTURE; MASTECTOMY; MEMORY DISORDER; MUCOSA INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM CANCER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SLEEP DISORDER; TREATMENT OUTCOME; VERTIGO;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; INJECTIONS, SPINAL; MENINGEAL NEOPLASMS; RECEPTOR, ERBB-2;

EID: 33747828928     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70864-6     Document Type: Article

References (10)

1. Glantz M., Cole B., Recht L., et al. High-dose intravenous methotrexate for patients with non leukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?. J Clin Oncol 16 (1998) 1561-1567
2. Siegal T., Horowitz A., and Gabizon A. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy. J Neurosurg 83 (1995) 1029-1037
3. Ozdogan M., Samur M., Bozcuk H., et al. Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection. Jpn J Clin Oncol 33 (2003) 229-231
4. Fuchs I., Loebbecke M., Buhler H., et al. HER2 in brain metastases: issues of concordance, survival and treatment. J Clin Oncol 20 (2002) 4130-4133
5. Burstein H., Lieberman G., Slamon D., et al. Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy. Ann Oncol 16 (2005) 1772-1777
6. Pestalozzi B., and Brignoli S. Trastuzumab in CSF. J Clin Oncol 18 (2000) 2350-2351
7. Grossi P., Ochiai H., Archer G., et al. Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer. Clin Cancer Res 15 (2003) 5514-5520
8. Laufman L., and Forsthoefel K. Use of intrathecal trastuzumab in a patient with carcinomatous meningitis. Clin Breast Cancer 2 (2001) 235
9. Stemmler H., Schmitt M., Harbeck N., et al. Application of intrathecal trastuzumab (Herceptin™) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. Oncol Rep 15 (2006) 1373-1377
10. Boogerd W., Dorresteijn L., van Der Sande J., et al. Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology 55 (2000) 117-119